To learn more, please see a recent article from The New York Times that featured our study findings
[2] [11] The American Diabetes Association recommends specific GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk
Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, et al
Individuals interested in adaptogenic support for cognition, resilience, and healthy aging
Users guide to mechanism of action and clinical use of GLP-1 receptor agonists
Yet, our knowledge of the functional properties of neurons that are born after injury within and outside the canonical neurogenic niches and their potential impact on circuit reorganization and on behavioral recovery is still building up